Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.44 -0.11%   SPY: 132.20 +0.17%
Quote Spy ILNS NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Intellect Neurosciences (ILNS)

@ May-22
Click the portfolio to add ILNS:
Close [X]
+ Add ILNS to Portfolio
  
  Last Trade: $0.04 -0.00 (-1.32%)
  Volume: 208,160 79% of avg daily volume
       
  Avg Volume: 264,856
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.04 - 0.04
  Open: 0.04
  Previous Close: 0.04
  52-wk Range: 0.03 - 0.18
  Market Cap: 3.3M
  P/E: 0.0
  Div Yield: $0.00 (0.00%)
Indexes
None
Spy ILNS

? Pro holders
? Member holders
? Items submitted
Additional ILNS resources



Customize Links
To see which Pros and tickerspy members own ILNS Sign up now
Latest ILNS Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

The War Against Alzheimer's Requires Thinking Small
PFE  ELN  AZN  ASTX  ILNS  
Linked by Investopedia Stock Analysis - January 02, 04:50PM from (stocks.investopedia.com)
A meaningful treatment for Alzheimer's is no longer out of reach. Find out which companies are in the race to find a cur  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Intellect Neurosciences CEO to Speak at Phacilitate CNS Leaders Forum Conference
ILNS  
Linked by GlobeNewswire - October 04, 07:00AM from (www.globenewswire.com)
NEW YORK, N.Y., Oct. 4, 2011 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS) a biopharmaceutical company with  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Intellect Neurosciences and ViroPharma Announce $126.5 Million Global Licensing Agreement to Develop and Commercialize OX1 for Friedreich's Ataxia and Other Neurodegenerative Diseases
VPHM  ILNS  
Linked by GlobeNewswire - September 30, 08:14AM from (www.globenewswire.com)
NEW YORK, Sept. 30, 2011 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS) announced today that Intellect has  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Intellect Neurosciences, Inc. Obtains Notice of Allowance for Alzheimer's Beta Amyloid Vaccine from the Japan Patent Office in Relation to the Company's RECALL-VAX(TM) Technology
ILNS  
Linked by GlobeNewswire - July 21, 08:19AM from (www.globenewswire.com)
NEW YORK, July 21, 2011 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc (OTCBB:ILNS), a biopharmaceutical company with an  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Intellect Neurosciences, Inc. Issues Letter to Shareholders
ILNS  
Linked by GlobeNewswire - May 24, 08:43AM from (www.globenewswire.com)
NEW YORK, May 24, 2011 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNSD), a biopharmaceutical company engaged  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Intellect Neurosciences CEO to Speak at International Conference on Drug Discovery for Brain Disorders in Panama City, Republic of Panama
ILNS  
Linked by GlobeNewswire - May 18, 07:00AM from (www.globenewswire.com)
NEW YORK, May 18, 2011 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Michael Grundman, MD, MPH, Alzheimer's Disease Clinical Trials Expert, Joins Intellect Neurosciences' Clinical Advisory Board
ILNS  
Linked by GlobeNewswire - May 16, 07:00AM from (www.globenewswire.com)
NEW YORK, May 16, 2011 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Intellect Neurosciences Files Orphan Drug Application in the United States for Its Clinical Candidate OX1 for the Treatment of Friedreich's Ataxia
ILNS  
Linked by GlobeNewswire - April 12, 06:00AM from (www.globenewswire.com)
NEW YORK, April 12, 2011 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Intellect Neurosciences Initiates Capital Markets Plan
ILNS  
Linked by GlobeNewswire - April 08, 02:05PM from (www.globenewswire.com)
NEW YORK, April 8, 2011 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Intellect Neurosciences, Inc. Receives New Patent on Clinical Stage Drug from the Israeli Patent and Trademark Office
ILNS  
Linked by GlobeNewswire - April 05, 06:00AM from (www.globenewswire.com)
NEW YORK, April 5, 2011 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource